Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CPT2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CPT2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CPT2 mRNA | affects expression | 16483693
|
C095105 |
bexarotene |
bexarotene results in increased expression of CPT2 mRNA | increases expression | 16648578
|
D001629 |
Bezafibrate |
Bezafibrate results in increased expression of CPT2 mRNA | increases expression | 16707586
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of CPT2 mRNA | affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CPT2 mRNA | decreases expression | 20106945
|
D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids results in increased expression of CPT2 mRNA | increases expression | 19805517
|
D004281 |
Docosahexaenoic Acids |
PPARA protein promotes the reaction [Docosahexaenoic Acids results in increased expression of CPT2 mRNA] | increases expression|increases reaction | 19805517
|
C045761 |
emeriamine |
emeriamine results in decreased activity of CPT2 protein | decreases activity | 12439634
|
D004958 |
Estradiol |
Estradiol results in decreased expression of CPT2 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CPT2 mRNA | increases expression | 17942748
|
D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in increased activity of CPT2 protein | increases activity | 15949695
|
D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in increased expression of CPT2 mRNA | increases expression | 15949695
|
D011345 |
Fenofibrate |
Fenofibrate results in increased expression of CPT2 mRNA | increases expression | 16707586
|
D005485 |
Flutamide |
Flutamide results in decreased expression of CPT2 mRNA | decreases expression | 17702527
|
C029424 |
hydrazine |
hydrazine results in increased expression of CPT2 mRNA | increases expression | 15282401
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of CPT2 mRNA | increases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CPT2 mRNA] | increases expression|increases reaction | 18467677
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of CPT2 mRNA | increases expression | 16221955
|
D010480 |
Perhexiline |
Perhexiline results in decreased activity of CPT2 protein | decreases activity | 12439634
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CPT2 mRNA | increases expression | 17950772 15375163 17426115 18301758
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of CPT2 mRNA] | increases expression|increases reaction | 17950772
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CPT2 mRNA | increases expression | 16940010 16707586
|
C009159 |
rapeseed oil |
rapeseed oil affects the expression of CPT2 mRNA | affects expression | 16177195
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CPT2 mRNA | increases expression | 19465110
|
C410666 |
tetradecylselenoacetic acid |
tetradecylselenoacetic acid results in increased expression of CPT2 mRNA | increases expression | 17185614
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.74 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.84 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.01 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.13 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.13 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.54 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.54 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.74 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.36 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.60 | 15885639 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
4.75 | 18448859 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.45 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
2.45 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
2.45 | 16920077 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.43 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.43 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
1.92 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.92 | 14630087 17261762 17018787 16675129 18497071 19861407 12948864 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.41 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.41 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.41 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.19 | 16247446 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18850075 18670907 16120746 |
OMIM:600649 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE |
marker/mechanism |
|
| |
OMIM:255110 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET |
marker/mechanism |
|
| |
OMIM:608836 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL |
marker/mechanism |
|
| |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.52 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.32 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.32 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.87 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.87 | 17681005 16105132 17110522 16919318 17333356 15861022 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.87 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.06 | 15668235 12621046 16354765 15340226 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.91 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
4.57 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.32 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
5.92 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.92 | 19739265 18071297 17906064 19085960 10915739 17522070 11287661 16081117 12153990 16109766 10663392 16781746 18713872 19370779 19420014 16485898 11743745 16177239 11739529 10774834 16393943 14725611 11529661 17562736 12594235 19416960 19164858 14986274 15619225 12705907 14550746 11461765 12392966 11834606 19923254 11421492 2444490 12958197 12540782 16227642 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.92 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.99 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
4.35 | 16707586 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
10.87 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.87 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.87 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.80 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.08 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.54 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
7.54 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.41 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.41 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.41 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.12 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.12 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.57 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.11 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.27 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.47 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.31 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
13.83 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.83 | 19176532 19772884 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.83 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 16959395 15340226 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.57 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.57 | 12083418 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
5.35 | 15356085 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.08 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.81 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.81 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.70 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.36 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.41 | 17937319 |
MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
8.25 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
8.25 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.25 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.96 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.96 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.34 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.61 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.61 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.61 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.84 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.84 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.84 | 15610895 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
4.90 | 17077332 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.12 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Perhexiline |
5.14 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.86 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
4.86 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.86 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.86 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.29 | 12969438 16610002 19014921 16611625 19460945 11587558 12587719 19784758 |
MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
4.29 | 17056761 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.14 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
13.83 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
13.83 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
13.83 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.83 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.83 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
5.91 | 18253720 18775883 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.91 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
2.50 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.50 | 19555203 11884234 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.04 | 11161223 |
MESH:D016778 |
Malaria, Falciparum |
|
Perhexiline |
5.86 | 16882315 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
6.02 | 19196723 19196722 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.02 | 16891317 11807958 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.38 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.46 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.68 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
Bezafibrate |
10.37 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
10.37 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.10 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.97 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.97 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.75 | 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.90 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.68 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.34 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.19 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.11 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.11 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.78 | 18514411 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.84 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.79 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.33 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.19 | 19401270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.30 | 16870215 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.58 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
4.90 | 15356085 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.13 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
9.31 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.31 | 11222880 11896295 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.78 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.67 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
3.67 | 3169114 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.20 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.19 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.33 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.46 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.99 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.84 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
3.06 | 19015929 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.52 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.06 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.24 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.21 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.87 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.19 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.88 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.44 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.34 | 17120751 |